Complete clinical remission and subsequent relapse of bronchiectasis-related (aa) amyloid induced nephrotic syndrome

Nephron

Volumn 74, Issue 3, 1996, Pages 572-576

  Goldsmith, D J A ^a   Roberts, I S P ^b   Short, C D ^a   Mallick, N P ^a  

^a The Renal Unit   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Amyloidosis; Nephrotic syndrome; Remission; Therapy

Indexed keywords

AMYLOID;

ADULT; AMYLOIDOSIS; ANTIBIOTIC THERAPY; ARTICLE; BRONCHIECTASIS; CASE REPORT; DIALYSIS; FEMALE; HUMAN; KIDNEY FAILURE; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; REMISSION; SURVIVAL; THORAX DRAINAGE;

EID: 0029958026     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189454     Document Type: Article

References (16)

1. Pepys MB: Amyloidosis: Some recent developments, Q J Med 1988:67:283-298.
2. Kyle RA, Gertz MA: Systemic amyloidosis, Crit Rev Oncol Hematol 1990;10:49-87.
3. Gertz MA, Kyle RA: Secondary systemic amyloidosis: Response and survival in 64 patients, Medicine (Baltimore) 1990;70:246-255.
4. Gertz MA, Kyle RA, Greipp PR: Response rates and survival in primary systemic amyloidosis, Blood 1991:77:257-262.
5. Maezewa A, Hiromura K, Mitsuhashi H, Tsu-kada Y, Kanai H, Yano S, Naruse T: Combined treatment with cyclophosphamide and prednisolone can induce remission of nephrotic syndrome in a patient with renal amyloidosis associated with rheumatoid arthritis, Clin Nephrol 1994:42:30-32.
6. Escalante A, Ehrcsmann GR, Quismorio FP Jr: Regression of reactive systemic amyloidosis due to ankylosing spondylitis following the administration of colchicine, Arthritis Rheum 1991:34:920-922.
7. Browning MJ, Banks RA, Tribe CR, Holling-worth P, Kingswood C, Mackenzie JC, Bacon PA: Ten years' experience of an amyloid clinic: A clinicopathological survey, QJ Med 1984:54: 213-227.
8. Michael J, Jones NF: Spontaneous remissions of nephrotic syndrome in renal amyloidosis, Br Med J 1978:1592-1593.
9. Watanabc T, Saniter T: Morphological and clinical features of systemic amyloidosis, Virchows Arch A Pathol Anal Histol 1975:366: 125-136.
10. il-labellcd scrum amyloid P component, N Engl J Med 1990;323:508-513.
11. Haw kins PN: Studies with radiolabelled serum amyloid P component provide evidence for turnover and regression of amyloid deposits in vivo, Clin Sci 1994;87:289-295.
12. Fritz DA, Luggcn ME, Hess EV: Unusual longevity in primary systemic amyloidosis: A 19-year survivor, Am J Med 1989;86:245-248.
13. Moroni G, Banfi G, Montoli A, Bucci A, Ber-tani T, Ravelli M, Pozzi C, Lconelli M, Lupo A, Volpi A, Pasquali S, Salvadco A: Chronic dialysis in patients with systemic amyloidosis: The experience in northern Italy, Clin Nephrol 1992:38:81-85.
14. Ylinen K, Gronhagen-Riska C, Honkanen E, Ekstrand A, Metsarinne K, Kulback B: Outcome of patients with secondary amyloidosis in dialysis treatment, Nephrol Dial Transplant 1992;7:908-912.
15. Sobh M, Refaie A, Moustafa F, Shokeir A, Has-san N, Sally S, Ghoneim M: Study of live donor kidney transplantation outcome in recipients with renal amyloidosis, Nephrol Dial Transplant 1994;9:704-708.
16. Isoniemi H, Eklund B, Hockerstadt K, Salmela K, Ahonen J: Renal transplantation in amyloidosis, Transplant Proc 1989;21:2039-2040.